Rare Disease Day is coming soon—a time to shine a light on the millions of people living with rare diseases, like scleroderma. At the Scleroderma Research Foundation (SRF), we believe...
Read More
CONQUEST is proud to be a sponsor of the EUSTAR Course 2025, which took place from February 6-8 in Bordeaux, France. Dr. Gregory Gordon, Chief Medical Officer of the Scleroderma...
Read More
Turning hope into action begins with a strategic approach to funding scleroderma research. When it comes to our core research portfolio, our Scientific Advisory Board, made up of some of...
Read More
Navigating clinical trials can feel overwhelming, but finding accurate, reliable information shouldn’t be. Our new clinical trial page is designed to empower you with resources and support to make informed...
Read More
"Our research would not be possible without the generous support of donors." – Ruslan Medzhitov, PhD, SRF-Funded Researcher Dr. Medzhitov, Yale School of Medicine & Howard Hughes Medical Institute,...
Read More
Since 1987, this dedicated community has stood shoulder to shoulder with the SRF, helping to drive research toward a cure for scleroderma. Because of your generosity and commitment, 2024 was...
Read More
Navigating clinical trials can feel overwhelming, but finding accurate, reliable information shouldn’t be. Our new clinical trial page is designed to empower you with resources and support to make informed...
Read More
Last week, the CONQUEST team had the incredible opportunity to visit Japan! 🇯🇵 CONQUEST is a global platform clinical trial created by the Scleroderma Research Foundation with input from partner...
Read More
The goal of all clinical trials is to be as inclusive as possible. However, it is necessary to develop specific inclusion and exclusion criteria. The reason for this is to...
Read More
This year, the SRF was proud to be represented by our Chief Medical Officer, Dr. Gregory Gordon, at the EULAR Congress 2024 in Vienna, Austria. Held from June 12-15, the…
